GO:0016020 | membrane | 2.49e-06 | 3.59e-02 | 3.101 | 6 | 90 | 1681 |
GO:0044267 | cellular protein metabolic process | 1.64e-05 | 2.36e-01 | 4.342 | 4 | 29 | 474 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0019083 | viral transcription | 4.61e-04 | 1.00e+00 | 5.891 | 2 | 10 | 81 |
GO:0006415 | translational termination | 5.31e-04 | 1.00e+00 | 5.788 | 2 | 10 | 87 |
GO:0006414 | translational elongation | 6.07e-04 | 1.00e+00 | 5.692 | 2 | 13 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.58e-04 | 1.00e+00 | 5.531 | 2 | 10 | 104 |
GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 2 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 9.10e-04 | 1.00e+00 | 5.398 | 2 | 11 | 114 |
GO:0019058 | viral life cycle | 9.26e-04 | 1.00e+00 | 5.386 | 2 | 13 | 115 |
GO:0016032 | viral process | 9.28e-04 | 1.00e+00 | 3.755 | 3 | 55 | 534 |
GO:0006413 | translational initiation | 1.20e-03 | 1.00e+00 | 5.198 | 2 | 17 | 131 |
GO:0006458 | 'de novo' protein folding | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 3 |
GO:0003735 | structural constituent of ribosome | 1.31e-03 | 1.00e+00 | 5.133 | 2 | 10 | 137 |
GO:0006457 | protein folding | 1.43e-03 | 1.00e+00 | 5.071 | 2 | 7 | 143 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 4 |
GO:0070469 | respiratory chain | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 5 |
GO:0003923 | GPI-anchor transamidase activity | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 5 |
GO:0042765 | GPI-anchor transamidase complex | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 5 |
GO:0003688 | DNA replication origin binding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 2 | 6 |
GO:0030957 | Tat protein binding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 3 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 6 |
GO:0016255 | attachment of GPI anchor to protein | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 7 |
GO:0000028 | ribosomal small subunit assembly | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 7 |
GO:0034235 | GPI anchor binding | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 7 |
GO:0070688 | MLL5-L complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 8 |
GO:0051604 | protein maturation | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 8 |
GO:0016071 | mRNA metabolic process | 3.43e-03 | 1.00e+00 | 4.430 | 2 | 31 | 223 |
GO:0006412 | translation | 3.64e-03 | 1.00e+00 | 4.386 | 2 | 20 | 230 |
GO:0043032 | positive regulation of macrophage activation | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 10 |
GO:0016070 | RNA metabolic process | 4.19e-03 | 1.00e+00 | 4.283 | 2 | 32 | 247 |
GO:0032727 | positive regulation of interferon-alpha production | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 11 |
GO:0033762 | response to glucagon | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 11 |
GO:0005743 | mitochondrial inner membrane | 5.24e-03 | 1.00e+00 | 4.117 | 2 | 8 | 277 |
GO:0042273 | ribosomal large subunit biogenesis | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 4 | 13 |
GO:0001530 | lipopolysaccharide binding | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 3 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 4 | 14 |
GO:0043234 | protein complex | 5.92e-03 | 1.00e+00 | 4.027 | 2 | 18 | 295 |
GO:0042026 | protein refolding | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 15 |
GO:0044822 | poly(A) RNA binding | 6.62e-03 | 1.00e+00 | 2.772 | 3 | 49 | 1056 |
GO:0050998 | nitric-oxide synthase binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 16 |
GO:0050870 | positive regulation of T cell activation | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 17 |
GO:0032733 | positive regulation of interleukin-10 production | 7.88e-03 | 1.00e+00 | 6.983 | 1 | 1 | 19 |
GO:0070062 | extracellular vesicular exosome | 8.64e-03 | 1.00e+00 | 2.002 | 4 | 104 | 2400 |
GO:0042100 | B cell proliferation | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 21 |
GO:0003756 | protein disulfide isomerase activity | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 22 |
GO:0030863 | cortical cytoskeleton | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 4 | 23 |
GO:0043236 | laminin binding | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 23 |
GO:0005829 | cytosol | 9.98e-03 | 1.00e+00 | 1.946 | 4 | 132 | 2496 |
GO:0042113 | B cell activation | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 25 |
GO:0006501 | C-terminal protein lipidation | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 2 | 26 |
GO:0043022 | ribosome binding | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 3 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 4 | 27 |
GO:0019894 | kinesin binding | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 28 |
GO:0001895 | retina homeostasis | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.53e-02 | 1.00e+00 | 6.022 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 2 | 38 |
GO:0032729 | positive regulation of interferon-gamma production | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 4 | 39 |
GO:0042110 | T cell activation | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 3 | 42 |
GO:0021762 | substantia nigra development | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 2 | 44 |
GO:0022625 | cytosolic large ribosomal subunit | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 6 | 49 |
GO:0004197 | cysteine-type endopeptidase activity | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 3 | 50 |
GO:0006986 | response to unfolded protein | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 2 | 50 |
GO:0005905 | coated pit | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 3 | 50 |
GO:0003725 | double-stranded RNA binding | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 5 | 53 |
GO:0030176 | integral component of endoplasmic reticulum membrane | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 2 | 53 |
GO:0045216 | cell-cell junction organization | 2.23e-02 | 1.00e+00 | 5.476 | 1 | 2 | 54 |
GO:0002039 | p53 binding | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 7 | 55 |
GO:0051087 | chaperone binding | 2.43e-02 | 1.00e+00 | 5.348 | 1 | 6 | 59 |
GO:0030141 | secretory granule | 2.55e-02 | 1.00e+00 | 5.277 | 1 | 2 | 62 |
GO:0034329 | cell junction assembly | 2.80e-02 | 1.00e+00 | 5.144 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 2.80e-02 | 1.00e+00 | 5.144 | 1 | 5 | 68 |
GO:0010467 | gene expression | 2.85e-02 | 1.00e+00 | 2.845 | 2 | 59 | 669 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.04e-02 | 1.00e+00 | 5.022 | 1 | 6 | 74 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 7 | 77 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 3 | 80 |
GO:0022904 | respiratory electron transport chain | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 1 | 85 |
GO:0050821 | protein stabilization | 3.61e-02 | 1.00e+00 | 4.772 | 1 | 2 | 88 |
GO:0006928 | cellular component movement | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 8 | 91 |
GO:0051082 | unfolded protein binding | 3.81e-02 | 1.00e+00 | 4.692 | 1 | 5 | 93 |
GO:0020037 | heme binding | 3.81e-02 | 1.00e+00 | 4.692 | 1 | 2 | 93 |
GO:0006364 | rRNA processing | 3.85e-02 | 1.00e+00 | 4.677 | 1 | 6 | 94 |
GO:0014069 | postsynaptic density | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 3 | 105 |
GO:0005506 | iron ion binding | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 4 | 105 |
GO:0005737 | cytoplasm | 4.38e-02 | 1.00e+00 | 1.352 | 4 | 110 | 3767 |
GO:0072562 | blood microparticle | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 8 | 112 |
GO:0044237 | cellular metabolic process | 4.77e-02 | 1.00e+00 | 4.361 | 1 | 5 | 117 |
GO:0006325 | chromatin organization | 4.81e-02 | 1.00e+00 | 4.348 | 1 | 5 | 118 |
GO:0005515 | protein binding | 4.97e-02 | 1.00e+00 | 0.997 | 5 | 184 | 6024 |
GO:0000790 | nuclear chromatin | 5.25e-02 | 1.00e+00 | 4.220 | 1 | 9 | 129 |
GO:0005615 | extracellular space | 5.52e-02 | 1.00e+00 | 2.329 | 2 | 17 | 957 |
GO:0016887 | ATPase activity | 5.69e-02 | 1.00e+00 | 4.102 | 1 | 7 | 140 |
GO:0061024 | membrane organization | 5.88e-02 | 1.00e+00 | 4.051 | 1 | 7 | 145 |
GO:0005739 | mitochondrion | 5.95e-02 | 1.00e+00 | 2.268 | 2 | 28 | 998 |
GO:0005769 | early endosome | 6.16e-02 | 1.00e+00 | 3.983 | 1 | 2 | 152 |
GO:0043687 | post-translational protein modification | 6.55e-02 | 1.00e+00 | 3.891 | 1 | 5 | 162 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 6.67e-02 | 1.00e+00 | 3.865 | 1 | 7 | 165 |
GO:0030424 | axon | 6.71e-02 | 1.00e+00 | 3.856 | 1 | 4 | 166 |
GO:0005759 | mitochondrial matrix | 9.12e-02 | 1.00e+00 | 3.398 | 1 | 14 | 228 |
GO:0005524 | ATP binding | 9.51e-02 | 1.00e+00 | 1.889 | 2 | 60 | 1298 |
GO:0043065 | positive regulation of apoptotic process | 1.06e-01 | 1.00e+00 | 3.165 | 1 | 10 | 268 |
GO:0005856 | cytoskeleton | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 12 | 291 |
GO:0006200 | ATP catabolic process | 1.16e-01 | 1.00e+00 | 3.041 | 1 | 15 | 292 |
GO:0019901 | protein kinase binding | 1.25e-01 | 1.00e+00 | 2.923 | 1 | 21 | 317 |
GO:0007411 | axon guidance | 1.26e-01 | 1.00e+00 | 2.914 | 1 | 13 | 319 |
GO:0003723 | RNA binding | 1.34e-01 | 1.00e+00 | 2.813 | 1 | 20 | 342 |
GO:0005925 | focal adhesion | 1.43e-01 | 1.00e+00 | 2.715 | 1 | 19 | 366 |
GO:0007155 | cell adhesion | 1.44e-01 | 1.00e+00 | 2.704 | 1 | 6 | 369 |
GO:0006508 | proteolysis | 1.47e-01 | 1.00e+00 | 2.669 | 1 | 9 | 378 |
GO:0009986 | cell surface | 1.56e-01 | 1.00e+00 | 2.580 | 1 | 11 | 402 |
GO:0043066 | negative regulation of apoptotic process | 1.64e-01 | 1.00e+00 | 2.503 | 1 | 31 | 424 |
GO:0007596 | blood coagulation | 1.75e-01 | 1.00e+00 | 2.401 | 1 | 18 | 455 |
GO:0005789 | endoplasmic reticulum membrane | 2.15e-01 | 1.00e+00 | 2.076 | 1 | 16 | 570 |
GO:0045087 | innate immune response | 2.24e-01 | 1.00e+00 | 2.012 | 1 | 24 | 596 |
GO:0005886 | plasma membrane | 2.93e-01 | 1.00e+00 | 0.897 | 2 | 45 | 2582 |
GO:0005654 | nucleoplasm | 3.74e-01 | 1.00e+00 | 1.152 | 1 | 76 | 1082 |
GO:0044281 | small molecule metabolic process | 4.09e-01 | 1.00e+00 | 0.989 | 1 | 58 | 1211 |
GO:0016021 | integral component of membrane | 5.88e-01 | 1.00e+00 | 0.278 | 1 | 27 | 1982 |
GO:0005634 | nucleus | 6.14e-01 | 1.00e+00 | 0.077 | 2 | 136 | 4559 |